Position in ABBV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$337,952
+$45,863 QoQ
Shares Held
1,343
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#3,513
of 4,153 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cannon Advisors, Inc. holds $1,477,410 across 2 Drug Manufacturers - General names. ABBV ranks #2 (22.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
950 | $1,139,458 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
1,343 | $337,952 |
All Filings in ABBV
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $337,952 | 1,343 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $292,089 | 1,343 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $306,862 | 1,343 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $322,535 | 1,393 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $242,234 | 1,305 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $269,442 | 1,286 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $228,522 | 1,286 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $257,908 | 1,306 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||